Literature DB >> 29937218

Gout and arrhythmias: In search for causation beyond association.

Georgios Giannopoulos1, Christos Angelidis2, Spyridon Deftereos2.   

Abstract

Gout is a systemic disease, characterized by the formation and deposition of crystals in tissues (mainly in and around the joints) of individuals with elevated serum uric acid levels. Lately, a considerable number of reports relating elevated uric acid and/or gout with rhythm disorders, such as atrial fibrillation, have been published. This review summarizes evidence linking common arrhythmias and hyperuricemia/gout and discusses questions or controversies that surround it. Overall, existing evidence may not be overwhelming, but strongly suggests a positive correlation between uric acid levels and common rhythm disorders. Needless to say that such a link - as a univariate association between the two - is to be expected, given the extensive overlap of risk factors and comorbidities of hyperuricemia/gout and arrhythmias. However, the observed associations seem to persist - in most studies - after extensive adjustment for potential confounders. Still, multivariable analyses of epidemiologically collected data cannot substitute for proof coming from basic and clinical studies. There is obviously a need for further basic research to establish a causal relationship between uric acid effects and arrhythmias, as well as translational studies and clinical trials to investigate the therapeutic implications of such a relationship. Simply put, we are fairly certain that there is association, but proof of causation is what we are still in want of.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  Arrhythmia; Atrial fibrillation; Gout; Hyperuricemia; Ventricular arrhythmia

Mesh:

Substances:

Year:  2018        PMID: 29937218     DOI: 10.1016/j.tcm.2018.06.004

Source DB:  PubMed          Journal:  Trends Cardiovasc Med        ISSN: 1050-1738            Impact factor:   6.677


  6 in total

1.  Serum Uric Acid Levels and Cardiometabolic Profile in Middle-Aged, Treatment-Naïve Hypertensive Patients.

Authors:  Panagiotis Theofilis; Vasilis Tsimihodimos; Aikaterini Vordoni; Rigas G Kalaitzidis
Journal:  High Blood Press Cardiovasc Prev       Date:  2022-05-07

2.  Hyperuricemia is a Risk Factor for One-Year Overall Survival in Elderly Female Patients with Acute Coronary Syndrome.

Authors:  Shi Tai; Xuping Li; Zhaowei Zhu; Liang Tang; Hui Yang; Liyao Fu; Xinqun Hu; Zhenfei Fang; Shenghua Zhou
Journal:  Cardiovasc Ther       Date:  2020-02-22       Impact factor: 3.023

3.  Hyperuricemia is associated with an increased prevalence of ventricular tachycardia and fibrillation in patients with ST-elevation myocardial infarction after primary percutaneous coronary intervention.

Authors:  Xianqing Hu; Shenwen Fu; Saibin Wang
Journal:  BMC Cardiovasc Disord       Date:  2022-04-26       Impact factor: 2.174

4.  Higher Serum Urate Levels Are Associated With an Increased Risk for Sudden Cardiac Death.

Authors:  Lisandro D Colantonio; Richard J Reynolds; Tony R Merriman; Angelo Gaffo; Jasvinder A Singh; Timothy B Plante; Ninad S Chaudhary; Nicole D Armstrong; Elsayed Z Soliman; Jeffrey R Curtis; S Louis Bridges; Leslie Lang; George Howard; Monika M Safford; Kenneth G Saag; Paul Muntner; Marguerite Ryan Irvin
Journal:  J Rheumatol       Date:  2021-06-15       Impact factor: 4.666

5.  Increased Overall Heart Rate Irregularity Risk by Hyperuricemia in the General Population: Results from the Korean National Health and Nutrition Examination Survey.

Authors:  Yeonghee Eun; Kyung-Do Han; Da Hye Kim; In Young Kim; Eun-Jung Park; Seulkee Lee; Hoon-Suk Cha; Eun-Mi Koh; Jaejoon Lee; Hyungjin Kim
Journal:  Medicina (Kaunas)       Date:  2020-09-24       Impact factor: 2.430

6.  Anti-inflammation effects of the total saponin fraction from Dioscorea nipponica Makino on rats with gouty arthritis by influencing MAPK signalling pathway.

Authors:  Qi Zhou; Hui Juan Sun; Shu Min Liu; Xi Hong Jiang; Qiu Yue Wang; Shuang Zhang; Dong Hua Yu
Journal:  BMC Complement Med Ther       Date:  2020-08-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.